Matches in SemOpenAlex for { <https://semopenalex.org/work/W2917783923> ?p ?o ?g. }
- W2917783923 endingPage "1473" @default.
- W2917783923 startingPage "1453" @default.
- W2917783923 abstract "Glioblastoma multiforme (GBM) has been considered the most aggressive glioma type. Temozolomide (TMZ) is the main first-line chemotherapeutic agent for GBM. Decreased mutS homolog 6 (MSH6) expression is clinically recognized as one of the principal reasons for GBM resistance to TMZ. However, the specific functions of MSH6 in GBM, in addition to its role in mismatch repair, remain unknown. Methods: Bioinformatics were employed to analyze MSH6 mRNA and protein levels in GBM clinical samples and to predict the potential cancer-promoting functions and mechanisms of MSH6. MSH6 levels were silenced or overexpressed in GBM cells to assess its functional effects in vitro and in vivo. Western blot, qRT-PCR, and immunofluorescence assays were used to explore the relevant molecular mechanisms. Cu2(OH)PO4@PAA nanoparticles were fabricated through a hydrothermal method. Their MRI and photothermal effects as well as their effect on restraining the MSH6-CXCR4-TGFB1 feedback loop were investigated in vitro and in vivo. Results: We demonstrated that MSH6 is an overexpressed oncogene in human GBM tissues. MSH6, CXCR4 and TGFB1 formed a triangular MSH6-CXCR4-TGFB1 feedback loop that accelerated gliomagenesis, proliferation (G1 phase), migration and invasion (epithelial-to-mesenchymal transition; EMT), stemness, angiogenesis and antiapoptotic effects by regulating the p-STAT3/Slug and p-Smad2/3/ZEB2 signaling pathways in GBM. In addition, the MSH6-CXCR4-TGFB1 feedback loop was a vital marker of GBM, making it a promising therapeutic target. Notably, photothermal therapy (PTT) mediated by Cu2(OH)PO4@PAA + near infrared (NIR) irradiation showed outstanding therapeutic effects, which might be associated with a repressed MSH6-CXCR4-TGFB1 feedback loop and its downstream factors in GBM. Simultaneously, the prominent MR imaging (T1WI) ability of Cu2(OH)PO4@PAA could provide visual guidance for PTT. Conclusions: Our findings indicate that the oncogenic MSH6-CXCR4-TGFB1 feedback loop is a novel therapeutic target for GBM and that PTT is associated with the inhibition of the MSH6-CXCR4-TGFB1 loop." @default.
- W2917783923 created "2019-03-02" @default.
- W2917783923 creator A5000206944 @default.
- W2917783923 creator A5000455963 @default.
- W2917783923 creator A5006007052 @default.
- W2917783923 creator A5037619900 @default.
- W2917783923 creator A5048639947 @default.
- W2917783923 creator A5049605332 @default.
- W2917783923 creator A5055055017 @default.
- W2917783923 creator A5062023751 @default.
- W2917783923 creator A5062331088 @default.
- W2917783923 creator A5080224324 @default.
- W2917783923 creator A5086902278 @default.
- W2917783923 creator A5088654377 @default.
- W2917783923 date "2019-01-01" @default.
- W2917783923 modified "2023-10-17" @default.
- W2917783923 title "Oncogenic MSH6-CXCR4-TGFB1 Feedback Loop: A Novel Therapeutic Target of Photothermal Therapy in Glioblastoma Multiforme" @default.
- W2917783923 cites W1486951179 @default.
- W2917783923 cites W1499386625 @default.
- W2917783923 cites W1829001348 @default.
- W2917783923 cites W1975104842 @default.
- W2917783923 cites W1986553481 @default.
- W2917783923 cites W1990391394 @default.
- W2917783923 cites W1991831751 @default.
- W2917783923 cites W1996488211 @default.
- W2917783923 cites W1996629339 @default.
- W2917783923 cites W2011810742 @default.
- W2917783923 cites W2028593825 @default.
- W2917783923 cites W2034661956 @default.
- W2917783923 cites W2041058430 @default.
- W2917783923 cites W2041657197 @default.
- W2917783923 cites W2066266313 @default.
- W2917783923 cites W2066564491 @default.
- W2917783923 cites W2074933477 @default.
- W2917783923 cites W2097478662 @default.
- W2917783923 cites W2109816625 @default.
- W2917783923 cites W2113613985 @default.
- W2917783923 cites W2114843025 @default.
- W2917783923 cites W2123434257 @default.
- W2917783923 cites W2127276996 @default.
- W2917783923 cites W2131554068 @default.
- W2917783923 cites W2131935157 @default.
- W2917783923 cites W2134153240 @default.
- W2917783923 cites W2138234499 @default.
- W2917783923 cites W2147587303 @default.
- W2917783923 cites W2148977460 @default.
- W2917783923 cites W2157985018 @default.
- W2917783923 cites W2158538733 @default.
- W2917783923 cites W2158649478 @default.
- W2917783923 cites W2165745669 @default.
- W2917783923 cites W2166045847 @default.
- W2917783923 cites W2189166455 @default.
- W2917783923 cites W2218010523 @default.
- W2917783923 cites W2236332245 @default.
- W2917783923 cites W2236918265 @default.
- W2917783923 cites W2264711365 @default.
- W2917783923 cites W2272762748 @default.
- W2917783923 cites W2296457333 @default.
- W2917783923 cites W2317397001 @default.
- W2917783923 cites W2319926262 @default.
- W2917783923 cites W2417504471 @default.
- W2917783923 cites W2464874208 @default.
- W2917783923 cites W247567061 @default.
- W2917783923 cites W2499735380 @default.
- W2917783923 cites W2518391872 @default.
- W2917783923 cites W2519684811 @default.
- W2917783923 cites W2527274603 @default.
- W2917783923 cites W2546146433 @default.
- W2917783923 cites W2546597833 @default.
- W2917783923 cites W2561278972 @default.
- W2917783923 cites W2582285180 @default.
- W2917783923 cites W2593616658 @default.
- W2917783923 cites W2599085091 @default.
- W2917783923 cites W2607129810 @default.
- W2917783923 cites W2607766282 @default.
- W2917783923 cites W2616891292 @default.
- W2917783923 cites W2736644190 @default.
- W2917783923 cites W2745996272 @default.
- W2917783923 cites W2761560873 @default.
- W2917783923 cites W2762044536 @default.
- W2917783923 cites W2765924646 @default.
- W2917783923 cites W2777876947 @default.
- W2917783923 cites W2793473305 @default.
- W2917783923 cites W2893450414 @default.
- W2917783923 cites W2897960809 @default.
- W2917783923 doi "https://doi.org/10.7150/thno.29987" @default.
- W2917783923 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6401508" @default.
- W2917783923 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30867843" @default.
- W2917783923 hasPublicationYear "2019" @default.
- W2917783923 type Work @default.
- W2917783923 sameAs 2917783923 @default.
- W2917783923 citedByCount "26" @default.
- W2917783923 countsByYear W29177839232020 @default.
- W2917783923 countsByYear W29177839232021 @default.
- W2917783923 countsByYear W29177839232022 @default.
- W2917783923 countsByYear W29177839232023 @default.
- W2917783923 crossrefType "journal-article" @default.
- W2917783923 hasAuthorship W2917783923A5000206944 @default.